Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 97: 58-66, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25983274

ABSTRACT

Activation of the peripheral angiotensin-(1-7)/Mas axis of the renin-angiotensin system produces important cardioprotective actions, counterbalancing the deleterious actions of an overactivity of Ang II/AT1 axis. In the present study we evaluated whether the chronic increase in Ang-(1-7) levels in the brain could ameliorate cardiac disorders observed in transgenic (mRen2)27 hypertensive rats through actions on Mas receptor. Sprague Dawley (SD) and transgenic (mRen2)27 hypertensive rats, instrumented with telemetry probe for arterial pressure (AP) measurement were subjected to 14 days of ICV infusion of Ang-(1-7) (200 ng/h) or Ang-(1-7) associated with Mas receptor antagonist (A779, 1 µg/h) or 0.9% sterile saline (0.5 µl/h) through osmotic mini-pumps. Ang-(1-7) infusion in (mRen2)27 rats reduced blood pressure, normalized the baroreflex control of HR, restored cardiac autonomic balance, reduced cardiac hypertrophy and pre-fibrotic alterations and decreased the altered imbalance of Ang II/Ang-(1-7) in the heart. In addition, there was an attenuation of the increased levels of atrial natriuretic peptide, brain natriuretic peptide, collagen I, fibronectin and TGF-ß in the heart of (mRen2)27 rats. Furthermore, most of these effects were mediated in the brain by Mas receptor, since were blocked by its selective antagonist, A779. These data indicate that increasing Ang-(1-7) levels in the brain can attenuate cardiovascular disorders observed in (mRen2)27 hypertensive rats, probably by improving the autonomic balance to the heart due to centrally-mediated actions on Mas receptor.


Subject(s)
Angiotensin II/analogs & derivatives , Angiotensin I/pharmacology , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Brain/drug effects , Hypertension/drug therapy , Peptide Fragments/pharmacology , Angiotensin II/pharmacology , Animals , Baroreflex/drug effects , Baroreflex/physiology , Blood Pressure/physiology , Brain/metabolism , Heart/drug effects , Heart/physiopathology , Heart Rate/drug effects , Heart Rate/physiology , Male , Myocardium/pathology , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Rats, Transgenic , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology
2.
Am J Physiol Regul Integr Comp Physiol ; 306(9): R681-92, 2014 May.
Article in English | MEDLINE | ID: mdl-24573182

ABSTRACT

Adult obese Zucker rats (OZR; >12 wk) develop elevated sympathetic nerve activity (SNA) and mean arterial pressure (MAP) with impaired baroreflexes compared with adult lean Zucker rats (LZR) and juvenile OZR (6-7 wk). In adult OZR, baroreceptor afferent nerves respond normally to changes in MAP, whereas electrical stimulation of baroreceptor afferent fibers produces smaller reductions in SNA and MAP compared with LZR. We hypothesized that impaired baroreflexes in OZR are linked to reduced activation of brain stem sites that mediate baroreflexes. In conscious adult rats, a hydralazine (HDZ)-induced reduction in MAP evoked tachycardia that was initially blunted in OZR, but equivalent to LZR within 5 min. In agreement, HDZ-induced expression of c-Fos in the rostral ventrolateral medulla (RVLM) was comparable between groups. In contrast, phenylephrine (PE)-induced rise in MAP evoked markedly attenuated bradycardia with dramatically reduced c-Fos expression in the nucleus tractus solitarius (NTS) of adult OZR compared with LZR. However, in juvenile rats, PE-induced hypertension evoked comparable bradycardia in OZR and LZR with similar or augmented c-Fos expression in NTS of the OZR. In urethane-anesthetized rats, microinjections of glutamate into NTS evoked equivalent decreases in SNA, heart rate (HR), and MAP in juvenile OZR and LZR, but attenuated decreases in SNA and MAP in adult OZR. In contrast, microinjections of glutamate into the caudal ventrolateral medulla, a target of barosensitive NTS neurons, evoked comparable decreases in SNA, HR, and MAP in adult OZR and LZR. These data suggest that OZR develop impaired glutamatergic activation of the NTS, which likely contributes to attenuated baroreflexes in adult OZR.


Subject(s)
Baroreflex , Hemodynamics , Obesity/physiopathology , Reflex, Abnormal , Solitary Nucleus/physiopathology , Animals , Arterial Pressure , Baroreflex/drug effects , Bradycardia/physiopathology , Bradycardia/prevention & control , Disease Models, Animal , Excitatory Amino Acid Agonists/administration & dosage , Excitatory Amino Acid Agonists/metabolism , Glutamic Acid/administration & dosage , Glutamic Acid/metabolism , Heart Rate , Hemodynamics/drug effects , Male , Microinjections , Obesity/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Sprague-Dawley , Rats, Zucker , Reflex, Abnormal/drug effects , Solitary Nucleus/drug effects , Solitary Nucleus/metabolism , Sympathetic Nervous System/physiopathology , Tachycardia/physiopathology , Time Factors , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
3.
Hypertension ; 63(5): 1078-85, 2014 May.
Article in English | MEDLINE | ID: mdl-24516106

ABSTRACT

We evaluated effects of chronic intracerebroventricular infusion of angiotensin (Ang)-(1-7) on cardiovascular and metabolic parameters in fructose-fed (FF) rats. After 6 weeks of fructose intake (10% in drinking water), Sprague-Dawley rats were subjected to intracerebroventricular infusion of Ang-(1-7) (200 ng/h; FF+A7 group) or 0.9% sterile saline (FF group) for 4 weeks with continued access to fructose. Compared with control rats, FF rats had increased mean arterial pressure and cardiac sympathetic tone with impaired baroreflex sensitivity. FF rats also presented increased circulating triglycerides, leptin, insulin, and glucose with impaired glucose tolerance. Furthermore, relative weights of liver and retroperitoneal adipose tissue were increased in FF rats. Glycogen content was reduced in liver, but increased in muscle. In contrast, fructose-fed rats subjected to chronic intracerebroventricular infusion of Ang-(1-7) presented reduced cardiac sympathetic tone with normalized mean arterial pressure, baroreflex sensitivity, glucose and insulin levels, and improved glucose tolerance. Relative weight of liver, and hepatic and muscle glycogen contents were also normalized in FF+A7 rats. In addition, FF+A7 rats had reduced mRNA expression for neuronal nitric oxide synthase and NR1 subunit of N-methyl-d-aspartate receptor in hypothalamus and dorsomedial medulla. Ang-(1-7) infusion did not alter fructose-induced hyperleptinemia and increased relative weight of retroperitoneal adipose tissue. There were no differences in body weights, neither in liver mRNA expression of phosphoenolpyruvate carboxykinase or glucose-6-phosphatase among the groups. These data indicate that chronic increase in Ang-(1-7) levels in the brain may have a beneficial role in fructose-fed rats by ameliorating cardiovascular and metabolic disorders.


Subject(s)
Angiotensin I/therapeutic use , Brain/metabolism , Dietary Carbohydrates/adverse effects , Fructose/adverse effects , Metabolic Syndrome/epidemiology , Metabolic Syndrome/prevention & control , Peptide Fragments/therapeutic use , Angiotensin I/administration & dosage , Angiotensin I/metabolism , Animals , Baroreflex/drug effects , Baroreflex/physiology , Blood Glucose/metabolism , Blood Pressure/drug effects , Blood Pressure/physiology , Body Weight/drug effects , Body Weight/physiology , Dietary Carbohydrates/pharmacology , Disease Models, Animal , Fructose/pharmacology , Glycogen/metabolism , Infusions, Intraventricular , Insulin/metabolism , Metabolic Syndrome/metabolism , Peptide Fragments/administration & dosage , Peptide Fragments/metabolism , Rats , Rats, Sprague-Dawley , Risk Factors
4.
Am J Physiol Heart Circ Physiol ; 303(3): H393-400, 2012 Aug 01.
Article in English | MEDLINE | ID: mdl-22661512

ABSTRACT

Angiotensin-(ANG)-(1-7) is known by its central and peripheral actions, which mainly oppose the deleterious effects induced by accumulation of ANG II during pathophysiological conditions. In the present study we evaluated whether a chronic increase in ANG-(1-7) levels in the brain would modify the progression of hypertension. After DOCA-salt hypertension was induced for seven days, Sprague-Dawley rats were subjected to 14 days of intracerebroventricular (ICV) infusion of ANG-(1-7) (200 ng/h, DOCA-A7) or 0.9% sterile saline. As expected, on the 21st day, DOCA rats presented increased mean arterial pressure (MAP) (≈40%), and impaired baroreflex control of heart rate (HR) and baroreflex renal sympathetic nerve activity (RSNA) in comparison with that in normotensive control rats (CTL). These changes were followed by an overactivity of the cardiac sympathetic tone and reduction of the cardiac parasympathetic tone, and exaggerated mRNA expression of collagen type I (≈9-fold) in the left ventricle. In contrast, DOCA rats treated with ANG-(1-7) ICV had an improvement of baroreflex control of HR, which was even higher than that in CTL, and a restoration of the baroreflex control of RSNA, the balance of cardiac autonomic tone, and normalized mRNA expression of collagen type I in the left ventricle. Furthermore, DOCA-A7 had MAP lowered significantly. These effects were not accompanied by significant circulating or cardiac changes in angiotensin levels. Taken together, our data show that chronic increase in ANG-(1-7) in the brain attenuates the development of DOCA-salt hypertension, highlighting the importance of this peptide in the brain for the treatment of cardiovascular diseases.


Subject(s)
Angiotensin I/administration & dosage , Antihypertensive Agents/administration & dosage , Blood Pressure/drug effects , Brain/drug effects , Desoxycorticosterone , Hypertension/prevention & control , Peptide Fragments/administration & dosage , Angiotensin I/blood , Angiotensin II/blood , Animals , Antihypertensive Agents/blood , Baroreflex/drug effects , Brain/metabolism , Brain/physiopathology , Collagen Type I/genetics , Collagen Type III/genetics , Disease Models, Animal , Heart Rate/drug effects , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , Hypertension/chemically induced , Hypertension/metabolism , Hypertension/physiopathology , Infusions, Intraventricular , Kidney/innervation , Lateral Ventricles , Male , Peptide Fragments/blood , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/physiopathology , Time Factors
5.
Hypertension ; 55(4): 889-96, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20212262

ABSTRACT

We evaluated the development of arterial hypertension, cardiac function, and collagen deposition, as well as the level of components of the renin-angiotensin system in the heart of transgenic rats that overexpress an angiotensin (Ang)-(1-7)-producing fusion protein, TGR(A1-7)3292 (TG), which induces a lifetime increase in circulating levels of this peptide. After 30 days of the induction of the deoxycorticosterone acetate (DOCA)-salt hypertension model, DOCA-TG rats were hypertensive but presented a lower systolic arterial pressure in comparison with DOCA-Sprague-Dawley (SD) rats. In contrast to DOCA-SD rats that presented left ventricle (LV) hypertrophy and diastolic dysfunction, DOCA-TG rats did not develop cardiac hypertrophy or changes in ventricular function. In addition, DOCA-TG rats showed attenuation in mRNA expression for collagen type I and III compared with the increased levels of DOCA-SD rats. Ang II plasma and LV levels were reduced in SD and TG hypertensive rats in comparison with normotensive animals. DOCA-TG rats presented a reduction in plasma Ang-(1-7) levels; however, there was a great increase in Ang-(1-7) ( approximately 3-fold) accompanied by a decrease in mRNA expression of both angiotensin-converting enzyme and angiotensin-converting enzyme 2 in the LV. The mRNA expression of Mas and Ang II type 1 receptors in the LV was not significantly changed in DOCA-SD or DOCA-TG rats. This study showed that TG rats with increased circulating levels of Ang-(1-7) are protected against cardiac dysfunction and fibrosis and also present an attenuated increase in blood pressure after DOCA-salt hypertension. In addition, DOCA-TG rats showed an important local increase in Ang-(1-7) levels in the LV, which might have contributed to the attenuation of cardiac dysfunction and prefibrotic lesions.


Subject(s)
Angiotensin I/genetics , Desoxycorticosterone/pharmacology , Hypertension/genetics , Peptide Fragments/genetics , Renin-Angiotensin System/genetics , Ventricular Remodeling/genetics , Analysis of Variance , Angiotensin I/blood , Animals , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type III/genetics , Collagen Type III/metabolism , Heart Function Tests , Hypertension/physiopathology , Hypertrophy, Left Ventricular/genetics , Hypertrophy, Left Ventricular/metabolism , Immunohistochemistry , Peptide Fragments/blood , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Transgenic , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...